Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Oramed Pharmaceuticals (ORMP) Other Non Operating Income (2024 - 2025)

Oramed Pharmaceuticals' Other Non Operating Income history spans 2 years, with the latest figure at -$714000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income changed N/A year-over-year to -$714000.0; the TTM value through Dec 2025 reached $44.5 million, changed N/A, while the annual FY2025 figure was -$606000.0, 448.28% down from the prior year.
  • Other Non Operating Income reached -$714000.0 in Q4 2025 per ORMP's latest filing, down from $32.3 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $32.3 million in Q3 2025 to a low of -$3.6 million in Q1 2025.